• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. DISPOSABLE DISTAL ATTACHMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. DISPOSABLE DISTAL ATTACHMENT Back to Search Results
Model Number D-201-11804
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 10/01/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H6 4581 - appropriate term / code not available is used to reflect mucosal injury, capnoperitoneum, subcutaneous emphysema, and reflux esophagitis.The evaluation of the event is ongoing.Should additional relevant information become available, a supplemental report will be submitted.This report is related to the following linked patient identifiers: (b)(6).
 
Event or Problem Description
Olympus reviewed the following literature titled "peroral endoscopic myotomy: short versus long esophageal myotomy for achalasia cardia: a randomized controlled non inferiority trial".Literature summary background and aims: the appropriate length of esophageal myotomy in peroral endoscopic myotomy (poem) for achalasia cardia remains unclear.This study aimed to compare the outcome of short (= 3 cm) and long (= 6 cm) esophageal myotomy in patients with type i and ii achalasia cardia.Methods: this single-blinded, randomized controlled noninferiority trial was conducted at a tertiary center between july 2021 and december 2021.Patients with achalasia types i and ii were randomized into short (=3 cm) and long (=6 cm) esophageal myotomy groups.The primary outcome of the study was clinical success (eckardt score =3) 1 year after the procedure.The secondary outcomes included a comparison of technical success, operating duration, occurrence of intraoperative adverse events, alterations in integrated relaxation pressure (irp), change in barium column height after 5 minutes (1 mo), and gastroesophageal reflux disease (3 mo) between the groups.Results: fifty-four patients were randomized into the short (n=27) or long (n=27) esophageal myotomy groups.Technical success rates were 100% (27/27) and 96.3% (26/27) in short myotomy (sm) and long myotomy (lm) groups, respectively.The clinical success rates were 96.3% (26/27) and 96.2% (25/26) in the sm and lm groups, respectively (p=0.998).The mean ( ±sd) length of the esophageal myotomy was 2.75±0.36 cm in the sm and 6.69±1.35 cm in the lm groups (p<0.001).The mean ( ±sd) procedure time for the sm and lm groups was 61.22±8.44 and 82.42±14.70 minutes (p<0.001), respectively.The mean integrated relaxation pressure (irp), eckardt score, adverse events, reflux esophagitis, symptomatic gastroesophageal reflux disease, and esophageal acid exposure (>6%) did not differ significantly between the 2 groups following poem treatment.Conclusions: short myotomy is noninferior to long myotomy in terms of clinical success, gastroesophageal reflux disease, and intraoperative adverse events at the short-term follow-up (p>0.05).Short myotomy resulted in a reduced operative time (p< 0.05).Adverse events the adverse events considered were those that led to prolongation of hospital stay or occurred intraoperatively or postoperatively, such as capnoperitoneum requiring needle aspiration and mucosal injuries requiring clip closure and bleeding.No major adverse events were reported in this study.Ten patients (18.9%) had minor intraoperative adverse events, with capnoperitoneum requiring needle aspiration in 3 patients and mucosal breach requiring endoclips in 2 others.In both groups, other insufflation-related adverse events, such as capnoperitoneum, subcutaneous emphysema, and minor intraoperative bleeding episodes, were not statistically significant.Reflux esophagitis was found in 18.5% and 30.7% of patients in the sm and lm groups, respectively.Type of adverse events/number of patients short myotomy (sm) minor bleeding - 3 patients mucosal injuries - 1 patient insufflation-related events -capnoperitoneum - 4 patients -needle aspiration - 1 patient -subcutaneous emphysema - 1 patient reflux esophagitis - 18.5% patients.Long myotomy (lm) minor bleeding - 2 patients mucosal injuries - 1 patient insufflation-related events -capnoperitoneum - 6 patients -needle aspiration - 2 patients -subcutaneous emphysema - 1 patient reflux esophagitis - 30.7% patients.
 
Additional Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the reported event was likely an accident, or a complication associated with a surgical procedure while using the subject device.There was no complaint reported on the subject device and no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DISPOSABLE DISTAL ATTACHMENT
Common Device Name
DISPOSABLE DISTAL ATTACHMENT
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key20790883
Report Number9614641-2024-02119
Device Sequence Number20580556
Product Code FDS
UDI-Device Identifier04953170278280
UDI-Public04953170278280
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K984358
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Study,Literature,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberD-201-11804
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/12/2024
Supplement Date Received by Manufacturer02/19/2025
Initial Report FDA Received Date11/27/2024
Supplement Report FDA Received Date02/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
FD-410LR; GIF-HQ190; KD-645L; UCR
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexUnknown
-
-